WebJim Shaffer, President and CEO, Aer Therapeutics It is estimated that approximately five million COPD patients in the United States have a mucus plug-high disease subtype. Conventional COPD treatments such as bronchodilators and supplemental oxygen do not treat the airway obstruction caused by mucus plugs. WebJimmy and Paul Shaffer perform Harry Styles' "As It Was" in the styles of Mick Jagger, David Bowie, Adam Sandler and more.The Tonight Show Starring Jimmy Fal...
Legend’s new CMO will bring in more cell therapy partners; …
Web1 dag geleden · Aer Therapeutics CEO Jim Shaffer (L) and founder John Fahy. April 13, 2024 07:00 AM EDT. Financing. Startups. Trio of VCs launches Gaelic-inspired Aer … WebAer Therapeutics plans to initiate a first-in-human Phase 1 clinical trial of the mucolytic drug later this year. "Our scientific founders led the pioneering research that uncovered mucus plugs as a key mechanism of disease in COPD, and their laboratories worked together to discover AER-01 as a novel mucolytic treatment,” said Jim Shaffer, President and CEO, … pnc cold spring
Shaopeng Yuan, PhD on LinkedIn: Aer Therapeutics Closes $36 …
Web13 apr. 2024 · Pulmonologists at Backus Hospital are now offering a procedure for patients with severe Chronic Obstructive Pulmonary Disease (COPD) that can greatly improve their breathing and their quality of life. Called Zephyr valves, the devices were approved in 2024 under the FDA’s breakthrough device status because of the need for new treatment … Web6 uur geleden · The company plans to conduct a first-in-human Phase 1 clinical trial of AER-01 in mid-2024. Jim Shaffer, President and CEO of Aer Therapeutics, says, “We are … Web14 apr. 2024 · A small Raleigh-based startup hopes to shake up the chronic obstructive pulmonary disease (COPD) market with a treatment for an underserved target—airway mucus plugs. Aer Therapeutics closed a $36 million Series A Thursday to take its inhaled mucolytic to the clinic. The new company is a spin-out from John Fahy’s lab at UCSF. pnc closing